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Abstract: 
Background: Incidence and prevalence rates of Multiple Sclerosis (MS) are 
generally higher in White populations than other ethnic groups. Relevant 
studies in the United Kingdom (UK) were conducted over 30 years ago.  
 
Objectives: The aim of this study is to provide updated ethnicity-specific 
MS prevalence rates in the UK.  
 
Methods: Electronic records from general practices in four east London 
boroughs were queried for the number of MS-diagnosed patients, grouped 
by ethnicity, into 5-year age bands. Compared against total registered GP 
patients in the area (c. 900,000), the age-standardised MS prevalence was 
calculated by ethnic group.  
 
Results: The overall age-standardised prevalence of MS was 111 per 
100,000 (152 for women, 70 for men), and 180, 74, and 29 for the White, 
Black and South Asian populations, respectively. The sex ratios 
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(female:male) were 2.2:1, 2.1:1 and 2.8:1 respectively.  
 
Conclusion: MS prevalence was considerably lower amongst Black and 
South Asian populations, compared to the White population, by 59% and 
84% respectively. However, compared to available data in Africa and South 
Asia, MS is several times more prevalent among Black people and South 
Asians living in the UK than their territorial ancestry. 
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Figure 1. Map of London showing borough boundaries with ‘east London’ catchment 
area highlighted. 
 
Figure 2. Ethnicity-specific MS Prevalence: Crude (white bars) and Age-Standardised 
(filled bars). 
 
Figure 3. MS Prevalence for Women by Age, Stratified by Ethnicity. 
 
Figure 4. MS Prevalence for Men by Age, Stratified by Ethnicity. 
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Abstract 
 
Background: Incidence and prevalence rates of Multiple Sclerosis (MS) are generally 
higher in White populations than other ethnic groups. Relevant studies in the United 
Kingdom (UK) were conducted over 30 years ago.  
 
Objectives: The aim of this study is to provide updated ethnicity-specific MS 
prevalence rates in the UK. 
 
Methods: Electronic records from general practices in four east London boroughs 
were queried for the number of MS-diagnosed patients, grouped by ethnicity, into 5-
year age bands. Compared against total register d GP patients in the area (c. 
900,000), the age-standardised MS prevalence was calculated by ethnic group. 
 
Results: The overall age-standardised prevalence of MS was 111 per 100,000 (152 
for women, 70 for men), and 180, 74, and 29 for the White, Black and South Asian 
populations, respectively. The sex ratios (female:male) were 2.2:1, 2.1:1 and 2.8:1 
respectively. 
 
Conclusion: MS prevalence was considerably lower amongst Black and South Asian 
populations, compared to the White population, by 59% and 84% respectively. 
However, compared to available data in Africa and South Asia, MS is several times 
more prevalent among Black people and South Asians living in the UK than their 
territorial ancestry. 
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Background 
Multiple sclerosis (MS) is an inflammatory demyelinating and neurodegenerative 
disease of the central nervous system. It is the most common chronic non-traumatic 
cause of disability in young adults, with a current prevalence rate in the United 
Kingdom (UK) of between 100-200 per 100,000.
1
 Significant disability develops after 
a mean of eight years disease duration.
2-9
 The cause of MS is unknown, although the 
evidence suggests MS is a complex disease with various contributing factors involved 
in risk.
10
 
 
Epidemiological studies of MS prevalence and incidence suggest that ethnicity may 
be a risk factor for the development of MS. Both MS incidence and prevalence is 
significantly higher among White people compared to people of other ethnicities.
11–
15
 The lowest country-level prevalence rates have been reported in countries with 
very small proportions of White people such as Japan (7.7/100,000) and Iran 
(32/100,000), whereas the highest rates are in countries with predominantly White 
populations, such as Norway (151/100,000) and the UK (203/100,000).
1,16-19
 What is 
more, in countries where there is a mix of local-born White and local-born non-
White residents, MS risk is almost always higher amongst White residents.
11–15,19–21
 
 
However, definitive studies to confirm a causal link between ethnicity and MS do not 
exist. The epidemiological work referred to above may be driven not by genetic 
differences, but by differing environmental exposures and behaviours.  Current 
hypotheses incorporate genetics to varying extents, such as: (i) mostly genetics 
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through differences in major histocompatibility complex (MHC) haplotypes;
22,23
 (ii) 
gene-environment interactions, such as the regulation of Class II Allele HLA-
DRB1*1501 by the vitamin D response element;
24
 and (iii) mostly environment 
through sun exposure,
25
 or viral infections such as Epstein-Barr virus.
26
 
 
The aim of this study is to update previous estimations of the UK prevalence of MS 
by ethnicity, last investigated over 30 years ago.
13,14
 Findings will apply to the local 
vicinity of the Barts MS service in the Royal London Hospital in east London. This 
should be taken into account when extrapolating to the UK as a whole. The local 
area within east London is ideal for studying the interaction between ethnicity and 
migration in the UK context because of its ethnic diversity. The Black and South Asian 
populations make up 44% of the area based on the 2011 Census, with the older 
generation of these ethnic minorities generally representing immigrants from a 
period of mass immigration from the Caribbean, Africa, and the Indian subcontinent 
in the 1950s and 1960s, and the younger generation mostly representing UK-born 
children of these settled immigrants. 
 
 
Methods 
The geographical area to calculate prevalence of MS was defined as the catchment 
area of the three nearest Clinical Commissioning Groups (CCG). These three are 
Tower Hamlets, Newham and City & Hackney, which correspond to the innermost 
boroughs in the east of London. Together they are referred to here simply as ‘east 
London’, highlighted in Figure 1. 
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[Figure 1 Placeholder] 
 
Data for both pwMS and the baseline population were extracted from a 2013 
anonymised general practice (GP) based patient records database. The GP database 
was accessed for this study by the Clinical Effectiveness Group (KB) of Barts and The 
London School of Medicine & Dentistry. The GP database records all patients 
registered with a GP using the ‘EMIS’ electronic patient records system. The total 
number of patients represents the ‘baseline population’. All patients coded with 
‘MS’ represent the total number of pwMS. Data were grouped into 5-year age-
groups and stratified by sex, ethnicity and CCG. Data from four GP practices in east 
London that do not use EMIS could not be included in this study. 
 
MS prevalence rates were standardised for age using the direct method based on 
the 2013 European Standard Population, and expressed as n/100,000.
27
 All 
prevalence rates reported here are age-standardised, unless otherwise specified. 
Using Microsoft Excel we calculated the overall MS prevalence rate, and specific MS 
prevalence rates stratified by sex and three ethnic groups: White, Black and South 
Asian. These ethnic groups are aggregates of standard ethnic classifications in the UK 
Census, which are used for self-classification on EMIS. ‘White’ includes Caucasian 
people such as those of British, American and European descent; ‘Black’ includes 
people of African and Caribbean descent; and ‘South Asian’ includes people of 
Indian, Bangladeshi, Pakistani and Sri Lankan descent. Because of small counts once 
divided into age, sex and ethnicity, 95% cConfidence intervals were calculated at 
95% confidence using the normal binomial method for proportionsa Poisson 
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distribution. Upper and lower bounds were calculated for each age-group to allow 
for direct age standardisation.  
 
Results 
A total of 907,151 patients were registered with GP practices of east London. Of 
these, 776 had a diagnosis of MS. Table 1 shows a breakdown of this population by 
sex and ethnicity. Confidence intervals are not shown as each upper and lower limit 
was within 1 case per 100,000 from the estimate, using the normal binomial method 
of deriving 95% confidence intervals for proportions. 
 
[Table 1 Placeholder] 
 
The overall prevalence (per 100,000) of MS in east London was 111. For women 
prevalence was 152 and for men 70. The prevalence for MS in the White population 
was 180, for Black people it was 74, and for South Asians 29. The sex ratios 
(female:male) were 2.2, 2.1 and 2.8, respectively. Figure 2 illustrates the sex and 
ethnicity-specific prevalence rates. Figures 3 and 4 illustrate the age-specific 
prevalence rates for each sex and ethnic group. Table 2 provides these rates, 
including 95% confidence intervals. In this table confidence intervals were derived 
using a Poisson distribution because many of the subgroups had fewer than 10 
counts. 
 
[Figure 2 Placeholder] 
[Figure 3 Placeholder] 
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[Figure 4 Placeholder] 
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Discussion 
To our knowledge this is the first study reporting ethnicity-specific prevalence of MS 
in east London. The overall prevalence of MS we detected was slightly lower than in 
a recent UK-wide study.
1
 Due to the limited sample size our prevalence rates at the 
extreme ends of the age spectrum are unreliable (see Table 2). Nevertheless, the 
prevalence peaks for the White population are virtually identical to those reported 
for the entire UK.
1,28
 We also calculated the incidence rates of MS by ethnicity using 
new cases in the year up to date we used to calculate prevalence rates. Differences 
in incidence by ethnicity roughly mirrored prevalence differences atIncidence rates 
per 100,000 (with Poisson distribution-derived 95% confidence intervals in brackets) 
were estimated at 8.6 (5.7-12.4)/100,000 for White people, 6.2 (2.8-11.7) /100,000 
for Black people, and 3.7 (1.8-6.7)/100,000 South Asians. The relative differences in 
incidence by ethnicity appear similar to our reported prevalence differences, 
however as indicated by overlapping confidence intervals around our incidence 
estimates these differences are not statistically significant. Confidence intervals were 
Poisson distribution-derived because of small numbers of incident cases. Also dDue 
to small numbers, these incidence rates are not age-adjusted. 
 
Ethnicity-specific MS risk in the UK and the US 
The relative risks by ethnicity in this study are in line with previous findings in the UK 
from the 1970s which indicated that ethnic minorities have a lower MS risk than 
White people.
13,14
 In one of these studies conducted in London, the incidence for 
Black people was about 16% that of White people, whilst the incidence for Indian 
Formatted: English (U.S.)
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men and women was 26% and 6% that of White men and women.
13
 In another study 
based in London and the Midlands, the incidence for Black people and South Asians 
combined was 13% that of White people.
14
 
 
Interestingly the findings in UK studies (including ours) for Black people are in 
contrast to findings from two recent studies US studies. One of these studies 
detected a higher incidence in Black compared to White military veterans.
11
 The 
other, which investigated members of the Kaiser Permanente managed care 
consortium in California, had similar findings.
12
 One possible explanation for the high 
MS risk in Black people in the US is selection bias in these studies, but other 
explanations to consider are genetic, environmental or behavioural differences 
between Black people in the US and the UK. Further work is needed in this area. 
 
MS Prevalence in Africa and South Asia 
What remains striking is the difference in MS prevalence between Black people and 
South Asians living in temperate climates compared to those living in their territorial 
ancestry. Even the highest prevalence reported for any sub-Saharan African country, 
0.24/100,000 in Ghana, is a small fraction of the prevalence of MS in Black people in 
east London (74/100,000).
29
 The difference between the prevalence of MS in South 
Asians living in east London (29/100,000) and, for example, people living in India 
(7/100,000) or Pakistan (5/100,000), is also impressive.
29
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The prevalence differences above may be explained by less extensive case 
ascertainment in less resourced countries.
30,31
 Indeed, estimates of prevalence in 
sub-Saharan Africa and South Asia by the Atlas of MS (MS International Federation) 
are based on very limited epidemiological studies of poor quality.
29
 However, an 
alternative, or additional, explanation would be increased exposure in the UK to 
environmental agents or behaviours that facilitate the development of MS.
10,24-26
 To 
further investigate true environmental or behavioural risk in future studies, we will 
test whether prevalence rates within ethnic minority groups vary depending on 
whether or not they were born in the UK. This will utilise our hospital-based dataset, 
the ‘Barts MS Database’, which includes migration and birth-country data that are 
unavailable through the GP database.  
 
Limitations  
The dataset on which our analysis is based has been derived from a system designed 
for clinical use by GPs. It is possible that pwMS may have been missed in the system. 
Residents who register with a GP outside of the catchment area, will inevitably be 
missed. A study of MS prevalence in Wales used a more extensive method for case 
ascertainment that overlapped multiple data sources.
28
 In that study, the most 
comprehensive case source was GP records, which is equivalent to the source we 
relied on in our study. GP records covered 73% of all cases, with only hospital 
records contributing a significant proportion of additional cases. A previous study by 
the same group had similar case ascertainment.
32
 In terms of diagnostic accuracy, 
the more recent Welsh study found that less than 2% had unclear diagnoses, which 
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is a testament to the reliability of GP records. Extrapolating from these studies, by 
only using GP records we are unlikely to have included misdiagnosed MS cases. 
However, we are likely to have underestimated prevalence estimates by 
approximately a quarter. Nevertheless, there appears to be little risk for biases in 
data by ethnicity as proportions of ethnic groups for pwMS in the east London GP 
database are very similar to the Barts MS Database, as such our relative comparisons 
between ethnicities are likely to be reliable. Once further developed, the Barts MS 
Database will be used in our future studies to account for missed pwMS and allow 
for diagnostic validation. 
 
Our findings must be interpreted with caution when generalised to the rest of the 
UK, because of the risk of selection bias. It is possible that the Black and South Asian 
populations in east London are not representative when compared to the Black and 
South Asian population in the rest of the UK. 
 
Conclusion 
This is the first study on the ethnicity-specific prevalence of MS in east London. With 
its ethnic diversity in a region where the overall risk of MS is amongst the highest in 
the world this cohort of pwMS may contribute to further explore the gene-
environment interaction that ultimately determines the risk of developing MS, and 
the course of the disease. 
 
[Table 2 Placeholder] 
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Figure 1. Map of London showing borough boundaries with ‘east London’ catchment area highlighted.  
269x232mm (72 x 72 DPI)  
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Table 1. Numbers of people with multiple sclerosis registered in GP practices within 
inner East London, by sex and ethnicity 
 
Ethnicity Female  Male  Total  
White 345 162 507 
Black 77 34 111 
South Asian 47 24 71 
Other 15 9 24 
Unknown 38 25 63 
Total 522 254 776 
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Figure 2. Ethnicity-specific MS Prevalence: Crude (white bars) and Age-Standardised (filled bars).  
213x131mm (150 x 150 DPI)  
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Figure 3. MS Prevalence for Women by Age, Stratified by Ethnicity  
146x83mm (150 x 150 DPI)  
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Figure 4. MS Prevalence for Men by Age, Stratified by Ethnicity  
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Table 2. Standardised prevalence rates (per 100,000) for each age group, specific to 
sex and ethnicity, including 95% confidence intervals* 
 
Female 
White 
95% Confidence 
Interval 
Female 
Black 
95% Confidence 
Interval 
Female 
South 
Asian 
95% Confidence 
Interval 
Age Rate Lower Upper Rate Lower Upper Rate Lower Upper 
0 to 4 0.0 0.0 1.7 0.0 0.0 2.8 0.0 0.0 1.3 
5 to 9 0.0 0.0 2.5 0.0 0.0 2.9 0.5 0.0 2.8 
10 to 14 0.0 0.0 3.9 0.0 0.0 3.8 0.7 0.0 3.6 
15 to 19 0.0 0.0 3.2 2.4 0.3 8.8 0.7 0.0 3.9 
20 to 24 2.4 0.9 5.2 0.0 0.0 3.3 3.4 1.2 7.3 
25 to 29 6.5 4.4 9.1 1.7 0.2 6.1 2.5 1.0 5.1 
30 to 34 7.8 5.3 11.0 10.0 5.0 17.9 2.0 0.6 4.7 
35 to 39 18.7 13.5 25.3 9.9 4.5 18.8 4.4 1.8 9.1 
40 to 44 22.7 15.9 31.4 15.1 8.2 25.3 7.6 3.3 14.9 
45 to 49 28.6 20.3 39.1 17.8 10.6 28.2 3.9 0.8 11.5 
50 to 54 37.3 27.2 49.9 9.7 4.2 19.2 3.2 0.4 11.4 
55 to 59 39.0 28.0 52.9 11.1 4.1 24.3 3.3 0.4 11.8 
60 to 64 32.4 22.0 45.9 0.0 0.0 8.4 0.0 0.0 5.4 
65 to 69 18.7 10.7 30.4 6.1 0.7 22.1 7.8 1.6 22.8 
70 to 74 17.2 8.9 30.0 11.0 3.0 28.0 0.0 0.0 7.9 
75 to 79 10.3 4.4 20.3 0.0 0.0 8.6 2.9 0.1 16.4 
80 to 84 4.0 1.1 10.2 0.0 0.0 9.7 0.0 0.0 10.8 
85 and over 1.7 0.2 6.3 5.6 0.1 31.3 0.0 0.0 18.4 
 
 
Male 
White 
95% Confidence 
Interval 
Male 
Black 
95% Confidence 
Interval 
Male 
South 
Asian  
95% Confidence 
Interval 
Age Rate Lower Upper Rate Lower Upper Rate Lower Upper 
0 to 4 0.0 0.0 1.6 0.0 0.0 2.7 0.0 0.0 1.2 
5 to 9 0.0 0.0 2.4 0.0 0.0 2.9 0.0 0.0 1.5 
10 to 14 0.0 0.0 3.9 0.0 0.0 3.7 0.0 0.0 1.9 
15 to 19 1.2 0.0 6.8 0.0 0.0 3.8 0.0 0.0 2.1 
20 to 24 0.6 0.0 3.5 0.0 0.0 4.1 0.0 0.0 1.3 
25 to 29 3.3 1.7 5.8 3.5 0.7 10.2 1.1 0.3 2.8 
30 to 34 4.6 2.7 7.4 2.4 0.3 8.5 0.9 0.2 2.7 
35 to 39 6.1 3.4 10.0 6.3 2.0 14.6 3.7 1.6 7.3 
40 to 44 8.7 5.0 14.1 4.7 1.3 12.0 1.3 0.2 4.6 
45 to 49 17.2 11.3 25.0 9.7 4.4 18.4 2.0 0.2 7.1 
50 to 54 17.0 10.6 25.7 6.6 2.2 15.5 3.6 0.7 10.5 
55 to 59 17.9 10.9 27.6 8.1 2.2 20.7 2.8 0.3 10.0 
60 to 64 13.0 6.9 22.2 3.3 0.1 18.4 0.0 0.0 6.7 
65 to 69 11.8 5.9 21.1 0.0 0.0 13.8 0.0 0.0 11.4 
70 to 74 9.9 3.6 21.5 3.8 0.1 21.2 0.0 0.0 9.4 
75 to 79 0.0 0.0 5.1 0.0 0.0 9.4 0.0 0.0 8.2 
80 to 84 1.4 0.0 7.8 0.0 0.0 11.2 0.0 0.0 8.9 
85 and over 0.0 0.0 5.6 0.0 0.0 22.4 0.0 0.0 21.4 
*95% Confidence Intervals are calculated directly from the Poisson distribution as each specific 
age, sex and ethnicity specific count of people with MS is less than 10 in most subgroups. 
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